Late last week, the GAVI Alliance board announced its plan to fund the introduction of vaccine

This is the fourth post in a blog mini-series from the Dengue Vaccine Initiativeabout the collaborative work being done to ensure future access to dengue vaccines in developing nations.

Financing research and development (R&D) for neglected tropical disease (NTDs) is a big challenge. The problem? Market failure.

This week in the Global Post, Dr. Fred Were, a pediatrician and specialist in neonatal medicine and National Chairman of the Kenya Pediatric Association (KPA), wrote about the dengue outbreak that swept his country in October. Dr.

Pages